Development of LNA Gapmer Oligonucleotide-Based Therapy for ALS/FTD Caused by the C9orf72 Repeat Expansion. (2020)

First Author: Sathyaprakash C
Attributed to:  UoOxford Confidence in Concept 2013 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/978-1-0716-0771-8_14

PubMed Identifier: 32865792

Publication URI: http://europepmc.org/abstract/MED/32865792

Type: Journal Article/Review

Volume: 2176

Parent Publication: Methods in molecular biology (Clifton, N.J.)

ISSN: 1064-3745